Charles River Laboratories has inaugurated a new biomedical diagnostic testing facility in Wilmington, Massachusetts, US.
The 60,000ft ² new facility will provide controlled environments, building monitoring and mechanical systems redundancy, as well as energy reduction through occupancy sensor-driven air distribution and lighting.
The facility will also provide an opportunity to utilize technology platforms that support drug development
Charles River Laboratories chairman, president and chief executive officer James Foster said the new facility provide the lab with additional capacity for growth, as well as the capability to utilize technology platforms to advance the R&D services it provide to its biopharmaceutical and academic clients.
"The opening of this building also demonstrates our commitment to investing in growth businesses and our employees, as well as doing business in the Commonwealth of Massachusetts," Foster added.